Minerva Neurosciences Q3 2026 Results: Turns Profitable, Net Income $101M
Minerva Neurosciences reported a net income of $100.7 million for the third quarter of 2026, primarily driven by a $109.6 million non-cash gain from the change in fair value of warrant liabilities. However, the company experienced a net loss of $7.2 million for the nine months ended September 30, 2026, as research and development expenses surged to $17.6 million compared to $3.6 million in the prior year.
- Key figure
- Net income $101M